{"altmetric_id":4016033,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["102644293117336"],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["cirugiaF","ALCASEItalia"],"posts_count":2}},"citation":{"abstract":"A 48-year-old woman was admitted to our hospital for sixth-line chemotherapy.A chest X-ray film and computed tomographic( CT)scan revealed a right-sided massive tumor with multiple lung tumors.Repeated treatment with carboplatin(AUC 6)on day 1 and nab-paclitaxel(100mg\/m2)on days 1, 8, and 15, every 28 days were effective in this patient.Chemotherapy with nab-paclitaxel may be effective for patients with multi-recurrent adenocarcinoma.","altmetric_jid":"4f6fa9263cf058f61000dcf4","authors":["Ishiura, Yoshihisa","Shiba, Yasutaka","Terasaki, Yasushi","Hinoue, Yoshinobu","Ishida, Youichi","Segawa, Masataka","Saitoh, Katsuhiko","Hirokami, Norikazu","Kasahara, Kazuo","Fujimura, Masaki"],"first_seen_on":"2015-05-20T12:10:14+00:00","funders":["niehs"],"issns":["0385-0684"],"issue":"4","journal":"Gan to kagaku ryoho Cancer chemotherapy","last_mentioned_on":1432238632,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25963700?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25963700"],"pmid":"25963700","pubdate":"2015-04-01T00:00:00+00:00","scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms","antineoplasticagents"],"title":"[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient].","type":"article","volume":"42","mendeley_url":"http:\/\/www.mendeley.com\/research\/nabpaclitaxel-platinum-chemotherapy-sixthline-therapy-nonsmall-cell-lung-cancer-patient"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":5128692,"mean":6.0685837216574,"rank":2708095,"this_scored_higher_than_pct":34,"this_scored_higher_than":1751329,"rank_type":"exact","sample_size":5128692,"percentile":34},"similar_age_3m":{"total_number_of_other_articles":171386,"mean":9.0184114595794,"rank":97602,"this_scored_higher_than_pct":33,"this_scored_higher_than":56929,"rank_type":"exact","sample_size":171386,"percentile":33},"this_journal":{"total_number_of_other_articles":600,"mean":0.56968280467446,"rank":56,"this_scored_higher_than_pct":79,"this_scored_higher_than":479,"rank_type":"exact","sample_size":600,"percentile":79},"similar_age_this_journal_3m":{"total_number_of_other_articles":26,"mean":0.404,"rank":2,"this_scored_higher_than_pct":84,"this_scored_higher_than":22,"rank_type":"exact","sample_size":26,"percentile":84}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Researcher":1,"Other":1},"by_discipline":{"Medicine and Dentistry":1,"Nursing and Health Professions":1}}},"geo":{"twitter":{"IT":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/cirugiaF\/status\/598428015337476097","license":"datasift","citation_ids":[4016033],"posted_on":"2015-05-13T10:02:11+00:00","author":{"name":"Cirug\u00eda","url":"http:\/\/fabumed.net\/ume\/cirugia\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1565649616\/favicon_normal.ico","description":"Herramienta para buscar, compartir, revisar y referenciar autores latinoamericanos que contribuyen a fortalecer la literatura m\u00e9dica de Latinoam\u00e9rica","id_on_source":"cirugiaF","tweeter_id":"382282545","geo":{"lt":null,"ln":null},"followers":439},"tweet_id":"598428015337476097"},{"url":"https:\/\/twitter.com\/ALCASEItalia\/status\/601478535254056960","license":"datasift","citation_ids":[4016033],"posted_on":"2015-05-21T20:03:52+00:00","author":{"name":"ALCASE Italia","url":"http:\/\/www.alcase.it","image":"https:\/\/pbs.twimg.com\/profile_images\/992780274\/Logo_alcase_normal.jpg","description":"ALCASE Italia \u00e8 la prima organizzazione italiana non-profit esclusivamente dedicata alla lotta al cancro del polmone","id_on_source":"ALCASEItalia","tweeter_id":"149186179","geo":{"lt":44.33203,"ln":7.55143,"country":"IT"},"followers":217},"tweet_id":"601478535254056960"}],"facebook":[{"title":"[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=857004614347963&id=102644293117336","license":"public","citation_ids":[4016033],"posted_on":"2015-05-21T15:00:02+00:00","summary":"DALLA LETTERATURA MEDICO-SCIENTIFICA\nIn questi anni, abbastanza giustamente peraltro, la chemioterapia del NSCLC inoperabile \u00e8 vista come una terapia di ripiego. Tuttavia, vi sono dei casi che presentano ottima tollerabilit\u00e0 e buone ricorrenti risposte all","author":{"name":"ALCASE Italia - Per la Lotta al Cancro del Polmone","url":"https:\/\/www.facebook.com\/102644293117336","facebook_wall_name":"ALCASE Italia - Per la Lotta al Cancro del Polmone","image":"https:\/\/graph.facebook.com\/102644293117336\/picture","id_on_source":"102644293117336"}}]}}